Home Data Calendar Blog

SMMT

Tables

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Common Stock Value 2.11 2.01 0.98 0.98 0.98 0.98 0.97 0.83 0.83 0.67 NA NA NA

Weighted Average Number Of Diluted Shares Outstanding NA 148.58 99.65 98.07 NA 97.45 90.65 82.82 NA 67.23 67.23 67.22 32.10

Weighted Average Number Of Shares Outstanding Basic NA 148.58 99.65 98.07 NA 97.45 90.65 82.82 NA 67.23 67.23 67.22 32.10

Earnings Per Share Basic 0.11 -0.14 -0.17 -0.22 -0.28 -0.20 -0.27 -0.21 -0.18 -0.26 -0.23 -0.09 -0.20

Earnings Per Share Diluted 0.11 -0.14 -0.17 -0.22 -0.28 -0.20 -0.27 -0.21 -0.18 -0.26 -0.23 -0.09 -0.20

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Revenue From Contract With Customer Excluding Assessed Tax 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Revenues 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Operating Expenses 21.43 22.62 15.94 27.21 30.89 25.61 29.91 22.56 18.10 22.71 19.35 16.48 12.63

Research And Development Expense 5.39 17.05 9.01 20.56 23.11 19.94 23.92 18.38 12.29 14.39 13.57 12.91 9.95

General And Administrative Expense 7.58 5.57 6.93 6.66 7.78 5.66 5.98 4.18 5.80 7.46 5.77 3.57 2.68

Operating Income Loss -20.30 -16.94 -12.69 -22.16 -26.05 -19.49 -23.73 -16.92 -13.55 -18.22 -15.36 -9.34 -6.19

Interest Expense 2.90 0.69 0.65 NA 0.04 0.00 0.22 NA NA NA NA NA NA

Interest Paid Net 0.00 NA NA NA 0.08 -0.08 NA NA NA NA NA NA NA

Allocated Share Based Compensation Expense 2.66 2.80 2.50 4.00 5.62 2.64 3.67 0.87 0.58 0.36 0.53 0.30 0.24

Net Income Loss -19.23 -21.39 -16.77 -21.40 -27.10 -19.60 -24.42 -17.49 -13.44 -17.70 -15.28 -6.13 -6.38

Comprehensive Income Net Of Tax -17.91 -21.43 -15.98 -23.16 -25.85 -20.46 -23.88 -16.81 -10.16 -15.45 -15.33 -10.76 -7.63

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Assets 664.17 155.33 95.72 116.47 113.37 128.67 145.52 140.79 102.50 56.87 NA NA NA

Liabilities 537.51 22.08 44.40 52.06 30.09 26.38 26.09 76.39 23.05 20.00 NA NA NA

Liabilities And Stockholders Equity 664.17 155.33 95.72 116.47 113.37 128.67 145.52 140.79 102.50 56.87 NA NA NA

Stockholders Equity 126.65 133.25 51.32 64.41 83.28 102.30 119.43 64.41 79.45 36.86 51.95 68.41 36.18

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Assets Current 656.71 137.12 79.40 99.44 97.31 102.21 121.48 125.22 87.67 42.08 NA NA NA

Cash 62.09 61.90 57.34 77.45 71.79 80.25 NA NA 66.42 NA NA NA NA

Cash And Cash Equivalents At Carrying Value 348.61 121.97 NA NA 71.79 NA 103.39 102.19 66.42 21.27 NA NA NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 648.61 121.97 57.34 77.45 71.79 80.25 103.39 102.19 66.42 21.27 36.41 54.94 21.64

Accounts Receivable Net Current 0.35 0.14 0.24 0.87 1.46 2.29 1.05 0.45 0.33 4.08 NA NA NA

Other Assets Current 0.49 0.43 2.30 1.48 1.20 1.19 0.96 0.98 1.52 1.67 NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Property Plant And Equipment Gross 2.20 NA NA NA 4.07 NA NA NA 1.85 NA NA NA NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 1.30 NA NA NA 3.38 NA NA NA 1.13 NA NA NA NA

Amortization Of Intangible Assets 0.22 0.22 0.23 0.25 0.25 0.26 0.26 0.26 0.42 0.30 0.26 0.27 NA

Property Plant And Equipment Net 0.91 0.93 1.09 0.96 0.69 0.66 0.76 0.68 0.72 0.72 NA NA NA

Goodwill 1.80 1.66 1.81 1.95 2.01 2.00 2.06 2.05 2.03 2.33 NA NA NA

Finite Lived Intangible Assets Net 0.00 7.95 8.90 9.87 10.40 10.61 11.16 11.36 11.52 11.10 NA NA NA

Other Assets Noncurrent 0.58 0.14 0.18 0.17 0.17 NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Liabilities Current 38.78 16.68 15.17 22.72 25.62 22.79 21.89 73.05 19.89 14.74 NA NA NA

Accounts Payable Current 0.35 1.43 3.57 6.96 4.37 5.88 6.95 4.11 6.14 2.49 NA NA NA

Accrued Liabilities Current 10.66 11.14 5.51 7.57 7.20 7.43 6.13 4.92 4.26 4.40 NA NA NA

Other Liabilities Current 0.66 0.21 0.27 0.68 0.90 1.03 0.66 0.58 0.73 0.35 NA NA NA

Contract With Customer Liability Current 0.00 0.00 3.23 5.10 7.94 7.51 7.14 7.42 8.37 7.11 NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Other Liabilities Noncurrent 1.43 2.42 2.59 2.75 2.78 2.69 2.69 2.60 2.51 2.28 NA NA NA

Operating Lease Liability Noncurrent 2.76 2.97 1.32 1.53 1.69 0.90 1.15 0.35 0.07 0.16 NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Stockholders Equity 126.65 133.25 51.32 64.41 83.28 102.30 119.43 64.41 79.45 36.86 51.95 68.41 36.18

Common Stock Value 2.11 2.01 0.98 0.98 0.98 0.98 0.97 0.83 0.83 0.67 NA NA NA

Additional Paid In Capital 504.77 493.55 391.22 388.33 384.05 377.21 373.88 295.13 293.37 242.40 NA NA NA

Retained Earnings Accumulated Deficit -378.33 -359.10 -337.72 -320.94 -299.55 -272.45 -252.85 -228.43 -210.95 -199.17 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -1.89 -3.22 -3.17 -3.96 -2.20 -3.44 -2.58 -3.12 -3.79 -7.03 NA NA NA

Stock Issued During Period Value New Issues 0.00 99.89 NA NA 0.00 -0.04 74.88 NA NA NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2.66 2.80 2.50 4.00 5.62 2.64 3.67 0.87 0.58 0.36 0.53 0.30 0.24

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Net Cash Provided By Used In Operating Activities 5.19 -8.55 -19.22 -19.00 -9.18 -23.57 -19.17 -20.67 -7.97 -16.65 -18.53 -4.96 NA

Net Cash Provided By Used In Investing Activities 0.01 0.02 -0.29 -0.36 -0.12 0.00 -0.15 -0.04 -0.05 -0.04 -0.13 -0.19 NA

Net Cash Provided By Used In Financing Activities 520.06 75.00 0.00 25.19 1.26 0.68 20.08 55.90 50.55 0.00 0.00 0.00 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Net Cash Provided By Used In Operating Activities 5.19 -8.55 -19.22 -19.00 -9.18 -23.57 -19.17 -20.67 -7.97 -16.65 -18.53 -4.96 NA

Net Income Loss -19.23 -21.39 -16.77 -21.40 -27.10 -19.60 -24.42 -17.49 -13.44 -17.70 -15.28 -6.13 -6.38

Increase Decrease In Accounts Receivable 1.41 -1.23 -0.70 -0.46 -0.93 1.37 0.59 0.11 -3.69 3.52 -1.29 1.25 NA

Increase Decrease In Accounts Payable -2.37 -1.04 -3.48 2.76 -1.36 -1.02 2.75 -2.08 3.49 -0.74 -3.81 2.70 NA

Share Based Compensation 2.66 2.80 2.50 4.00 5.62 2.64 3.67 0.87 0.58 0.36 0.53 0.30 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Net Cash Provided By Used In Investing Activities 0.01 0.02 -0.29 -0.36 -0.12 0.00 -0.15 -0.04 -0.05 -0.04 -0.13 -0.19 NA

Payments To Acquire Property Plant And Equipment -0.01 -0.02 0.29 0.36 0.12 -0.00 0.15 0.04 0.05 0.21 0.13 0.03 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Net Cash Provided By Used In Financing Activities 520.06 75.00 0.00 25.19 1.26 0.68 20.08 55.90 50.55 0.00 0.00 0.00 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30

Revenues 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Euro Farma Laboratorios S A, License And Service -0.02 NA NA NA NA NA NA NA NA NA NA NA NA

License And Service 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Revenue From Contract With Customer Excluding Assessed Tax 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Euro Farma Laboratorios S A, License And Service -0.02 NA NA NA NA NA NA NA NA NA NA NA NA

License And Service 0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

0.00 0.22 0.23 0.25 0.25 1.31 0.06 0.19 0.18 0.18 0.17 0.32 0.15

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Other Nonoperating Income Expense

Balance Sheet

Finite Lived Intangible Assets Net

Assets

Property Plant And Equipment Net

Current Assets

Accounts Receivable Net Current

NonCurrent Assets

Finite Lived Intangible Assets Net

PropertyPlantAndEquipmentNet

Property Plant And Equipment Net

Liabilities

Operating Lease Liability

Current Liabilities

Contract With Customer Liability Current

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Payments To Acquire Property Plant And Equipment

Shares

Weighted Average Number Of Diluted Shares Outstanding

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Other Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Due Year Four

FiniteLivedIntangibleAssets

Finite Lived Intangible Assets Net

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)

Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components